BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 194981)

  • 1. Increased binding and killing of neuraminidase-galactose oxidase-treated tumor cells by normal macrophages.
    Piessens WF
    J Immunol; 1977 Jul; 119(1):167-72. PubMed ID: 194981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of lymphocyte cytotoxicity by modification of the effector or target cells with periodate or with neuraminidase and galactose oxidase.
    Novogrodsky A
    J Immunol; 1975 Mar; 114(3):1089-93. PubMed ID: 163281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactose oxidase-induced blastogenesis of human lymphocytes and the effect of macrophages on the reaction.
    Biniaminov M; Ramot B; Rosenthal E; Novogrodsky A
    Clin Exp Immunol; 1975 Jan; 19(1):93-8. PubMed ID: 1204241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells.
    Bucana C; Hoyer LC; Hobbs B; Breesman S; McDaniel M; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4444-58. PubMed ID: 187323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and growth factor requirements for activation of human T lymphocytes by neuraminidase and galactose oxidase-treated lymphoid cells.
    Lipkowitz S; Rubin AL; Stenzel KH; Novogrodsky A
    J Immunol; 1983 Jun; 130(6):2702-7. PubMed ID: 6602177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The requirement for macrophage-lymphocyte interaction in T lymphocyte proliferation induced by generation of aldehydes on cell membranes.
    Greineder DK; Rosenthal AS
    J Immunol; 1975 Oct; 115(4):932-8. PubMed ID: 170338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor properties of lymphocytes activated by the oxidizing mitogens.
    Wang J; Suthanthiran M; Walle A; Lagman M; Schwartz R; Murthi V; Novogrodsky A; Stenzel KH
    J Immunol; 1986 Jun; 136(12):4735-9. PubMed ID: 3011903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation of human peripheral lymphocytes by galactose oxidase.
    Dixon JF; Parker JW; O'Brien RL
    J Immunol; 1976 Mar; 116(3):575-8. PubMed ID: 1254945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of neuraminidase and galactose oxidase on murine lymphocytes. I. Evidence for the differential delivery of signal(s) leading to cell proliferation and the differentiation of cytotoxic T cells.
    Kuppers RC; Henney CS
    J Immunol; 1977 Dec; 119(6):2163-71. PubMed ID: 303259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blastogenesis induced in human lymphocytes by neuraminidase-galactose oxidase treated autologous and allogeneic cells.
    O'Brien RL; Parker JW; Dixon JF; Stanton RH
    Cell Immunol; 1977 Jan; 28(1):101-8. PubMed ID: 188554
    [No Abstract]   [Full Text] [Related]  

  • 12. Cooperative pathway induction of T lymphocyte mitogen stimulation.
    Peters JH; Schimmelpfeng L
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):169-82. PubMed ID: 218373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysis of tumor cells by antibody and complement. VI. Enhanced killing of enzyme-pretreated tumor cells.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1976 Mar; 116(3):661-8. PubMed ID: 176270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.
    Piessens WF; Churchill WH; David
    J Immunol; 1975 Jan; 114(1 Pt 2):293-9. PubMed ID: 163856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogenic properties of neuraminidase and galactose oxidase-treated lymphoblastoid cells and plasma membranes for peripheral blood lymphocytes.
    Arnold A; Rubin AL; Novogrodsky A; Stenzel KH
    J Immunol; 1984 Nov; 133(5):2569-76. PubMed ID: 6332856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The function of macrophages in T-lymphocyte antigen recognition.
    Rosenthal AS; Shevach EM
    Contemp Top Immunobiol; 1976; 5():47-90. PubMed ID: 61101
    [No Abstract]   [Full Text] [Related]  

  • 17. Abrogation of tumor rejection by trypan blue.
    Kreider JW; Bartlett GL; DeFreitas E
    Cancer Res; 1978 Apr; 38(4):1036-40. PubMed ID: 205342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface glycoproteins of rat lymphocytes. I. Correlation of mitogenic stimulation by periodate or neuraminidase and galactose oxidase with the presence of papain-sensitive glycoproteins.
    Mitchell RN; Bowers WE
    J Immunol; 1978 Dec; 121(6):2181-92. PubMed ID: 214497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors involved in the cytotoxicity of normal guinea pig serum for cells of murine tumor TA3 sublines treated with neuraminidase.
    Hughes RC; Palmer PD; Sanford BH
    J Immunol; 1973 Oct; 111(4):1071-80. PubMed ID: 4728677
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of concanavalin A on the killing of tumor cells by antibody and complement.
    Boyle MD; Langone JJ; Ohanian SH; Borsos T
    J Immunol; 1977 May; 118(5):1626-30. PubMed ID: 192797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.